Argonautica Private Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $560K | Sell |
8,112
-78
| -1% | -$5.38K | 0.18% | 106 |
|
|
2025
Q1 | $569K | Buy |
8,190
+726
| +10% | +$50.4K | 0.2% | 101 |
|
|
2024
Q4 | $642K | Sell |
7,464
-27
| -0.4% | -$2.32K | 0.21% | 94 |
|
|
2024
Q3 | $892K | Buy |
7,491
+43
| +0.6% | +$5.12K | 0.3% | 71 |
|
|
2024
Q2 | $1.06M | Sell |
7,448
-1
| -0% | -$143 | 0.36% | 62 |
|
|
2024
Q1 | $956K | Buy |
7,449
+1,655
| +29% | +$212K | 0.34% | 66 |
|
|
2023
Q4 | $599K | Sell |
5,794
-18
| -0.3% | -$1.86K | 0.25% | 84 |
|
|
2023
Q3 | $529K | Buy |
5,812
+24
| +0.4% | +$2.18K | 0.24% | 83 |
|
|
2023
Q2 | $468K | Buy |
5,788
+922
| +19% | +$74.6K | 0.21% | 92 |
|
|
2023
Q1 | $387K | Sell |
4,866
-1,142
| -19% | -$90.9K | 0.2% | 97 |
|
|
2022
Q4 | $407K | Buy |
+6,008
| New | +$407K | 0.21% | 91 |
|